Neuberger Berman Group
KYNB

Neuberger Berman Group’s Kyntra Bio KYNB Stock Holding History

Neuberger Berman Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,068
Closed -$23.7K – 1865
2023
Q4 		$23.7K Buy
1,068
+557
+109% +$8.4K ﹤0.01% 1831
2023
Q3 		$11K Buy
+511
New +$20.1K ﹤0.01% 1787
2020
Q4 		– Sell
-310
Closed -$319K – 1693
2020
Q3 		$319K Buy
+310
New +$334K ﹤0.01% 1436
2019
Q3 		– Sell
-260
Closed -$294K – 1559
2019
Q2 		$294K Sell
260
-72
-22% -$78.8K ﹤0.01% 1406
2019
Q1 		$451K Sell
332
-68
-17% -$92.2K ﹤0.01% 1279
2018
Q4 		$463K Buy
+400
New +$450K ﹤0.01% 1275

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Neuberger Berman Group's KYNB Position: Q1 2024 in Review

Neuberger Berman Group sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 1,068 shares — an estimated $23.7K sold.

Neuberger Berman Group first reported a position in KYNB in Q4 2018 and held it in 6 quarters. The position peaked at $463K in Q4 2018. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Neuberger Berman Group reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • Neuberger Berman Group sold 1,068 Kyntra Bio shares in Q1 2024, an estimated $23.7K.
  • Neuberger Berman Group first reported a position in Kyntra Bio in Q4 2018 and held it in 6 quarters.
  • Neuberger Berman Group's Kyntra Bio position peaked at $463K in Q4 2018.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Neuberger Berman Group's 13F filing for Q1 2024, filed 13 May 2024.